Irvine, Calif.-based Rebound Therapeutics raised $16.5 million in a round of Series B financing. The minimally invasive surgical device developer intends to use the money to develop products, scale up manufacturing and commercialization activities and secure regulatory approvals.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.